To the extent possible under law, the person who associated CC0 with this work has waived all copyright and related or neighboring rights to this work.
General Information
DRAVP ID DRAVPe02721
Peptide Name -
Sequence CHSLRNAFC
Sequence Length 9
UniProt ID No Entry Found
Taxon ID None
Source Synthetic-Construct(phage display selection of cyclic nonapeptides)
Validation Experimentally Validated
Origin Information
Gene Name/ID Not Available
GenBank Not Available
Amino Acid position Not Available
Domain Accession ID Not Available
Nucleotide sequence ID Not Available
Molecular Type Not Available
Chromosomal Position Not Available
Activity Information
Target Organism SNV
Assay Focus reduction assay
Activity
Hemolytic Activity No hemolysis information or data found in the reference(s) presented in this entry
Cytotoxicity No cytotoxicity information found in the reference(s) presented
Binding Target Membrane
Mechanism Inhibit Virus Entry
Structure Information
PDB ID None
Predicted Structure Download No predicted structure available
Linear/Cyclic Cyclic
N-terminal Modification Free
C-terminal Modification Free
Other Modification None
Stereochemistry L
Physicochemical Information
Formula H80C118N28O22S2
Absent amino acids IKMTVW
Common amino acids CH
Mass 1906.11
Pl 6.92409191131591
Basic residues 5
Acidic residues 3
Hydrophobic residues 5
Net charge 2
Boman Index 1.37
Hydrophobicity -1.44
Aliphatic Index 19.33
Half Life
Extinction Coefficient cystines 1490
Absorbance 280nm 0.781695769882196
Polar residues 10
Literature Information
Literature 1
Title Multivalent presentation of antihantavirus peptides on nanoparticles enhances infection blockade.
Pubmed ID 18391034
Reference Antimicrob Agents Chemother. 2008
Author Hall PR, Hjelle B, Brown DC, Ye C, Bondu-Hawkins V, Kilpatrick KA, Larson RS.
To the extent possible under law, the person who associated CC0 with this work has waived all copyright and related or neighboring rights to this work.